ICOS and allergic disease: The results of many recent studies have suggested that ICOS+ Tregs are an activated subset with strong inhibitory ability that can prevent the onset or restrain the progression of most autoimmune and allergic diseases, while they can also contribute to the immunosuppression of tumors.